5 Comments

If Altman was regularly ignoring the safeguards his co-founder - who is the AI expert, BTW - then the board did the right thing. This belief that the only thing that matters is whether a company is increasing marketshare and value, regardless of ethics, is how we ended up with Purdue Pharma and Oxycontin. Would you work for a company that regularly ignores the warnings of its resident experts - the ones without whom the technology would not exist - just to make money?

I wouldn't.

Expand full comment